Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 42 | 49 | 45 | 53 | 56 | 61 | 61 | 67 | 75 | 82 | 82 | 92 |
| Expenses | 31 | 35 | 33 | 40 | 44 | 45 | 46 | 50 | 54 | 57 | 56 | 63 |
| Operating Profit | 11 | 14 | 12 | 13 | 13 | 16 | 15 | 16 | 21 | 25 | 26 | 28 |
| OPM % | 26% | 29% | 26% | 24% | 22% | 26% | 25% | 25% | 28% | 30% | 31% | 31% |
| Other Income | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Interest | 0 | 0 | 0 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 2 | 2 | 3 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 |
| Profit before tax | 9 | 12 | 9 | 7 | 5 | 10 | 9 | 10 | 15 | 18 | 20 | 22 |
| Tax % | 26% | 24% | 25% | 26% | 27% | 25% | 49% | 25% | 26% | 26% | 26% | 26% |
| Net Profit | 7 | 9 | 7 | 6 | 4 | 8 | 5 | 8 | 11 | 14 | 15 | 17 |
| EPS in Rs | 0.42 | 0.58 | 0.43 | 0.34 | 0.24 | 0.46 | 0.28 | 0.46 | 0.66 | 0.84 | 0.90 | 1.02 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 43 | 55 | 71 | 82 | 96 | 103 | 136 | 156 | 177 | 232 | 306 | 331 |
| Expenses | 35 | 42 | 56 | 66 | 75 | 79 | 99 | 114 | 129 | 174 | 217 | 231 |
| Operating Profit | 8 | 12 | 14 | 16 | 21 | 23 | 37 | 42 | 48 | 57 | 88 | 100 |
| OPM % | 19% | 23% | 20% | 20% | 22% | 23% | 28% | 27% | 27% | 25% | 29% | 30% |
| Other Income | 1 | 0 | 0 | 2 | 1 | 2 | 2 | 3 | 4 | 3 | 5 | 6 |
| Interest | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 10 | 9 | 8 |
| Depreciation | 3 | 3 | 4 | 4 | 5 | 6 | 7 | 8 | 9 | 19 | 22 | 22 |
| Profit before tax | 4 | 8 | 10 | 12 | 17 | 18 | 32 | 36 | 41 | 32 | 63 | 75 |
| Tax % | 21% | 33% | 32% | 30% | 30% | 29% | 26% | 26% | 25% | 32% | 26% | |
| Net Profit | 3 | 5 | 7 | 9 | 12 | 13 | 24 | 27 | 30 | 21 | 47 | 56 |
| EPS in Rs | 0.20 | 0.33 | 0.41 | 0.53 | 0.72 | 0.78 | 1.46 | 1.64 | 1.86 | 1.31 | 2.87 | 3.42 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 22% | 24% | 25% | 35% | ||
| Compounded Profit Growth | 31% | 30% | 20% | 138% | ||
| Stock Price CAGR | 31% | 17% | 21% | 145% | ||
| Return on Equity | 23% | 23% | 21% | 25% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | -6 | -3 | 8 | 14 | 23 | 34 | 47 | 70 | 97 | 127 | 148 | 194 |
| Borrowings | 14 | 10 | 6 | 15 | 10 | 9 | 29 | 29 | 50 | 82 | 89 | 84 |
| Other Liabilities | 7 | 6 | 8 | 8 | 10 | 11 | 13 | 13 | 18 | 38 | 32 | 38 |
| Total Liabilities | 31 | 29 | 38 | 53 | 60 | 70 | 105 | 129 | 182 | 264 | 286 | 332 |
| Fixed Assets | 25 | 23 | 24 | 37 | 36 | 39 | 74 | 75 | 84 | 206 | 248 | 248 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 6 | 34 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 6 | 7 | 14 | 16 | 24 | 31 | 29 | 48 | 63 | 57 | 38 | 84 |
| Total Assets | 31 | 29 | 38 | 53 | 60 | 70 | 105 | 129 | 182 | 264 | 286 | 332 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 5 | 6 | 10 | 12 | 16 | 11 | 26 | 29 | 32 | 38 | 58 | 79 |
| Cash from Investing Activity | -1 | -1 | -4 | -19 | -9 | -8 | -43 | -29 | -48 | -56 | -51 | -17 |
| Cash from Financing Activity | -5 | -5 | -5 | 6 | -5 | -4 | 18 | -1 | 16 | 20 | -2 | -21 |
| Net Cash Flow | -0 | -0 | 1 | -1 | 1 | -1 | 1 | -0 | 0 | 3 | 4 | 41 |
| Free Cash Flow | 5 | 5 | 6 | -3 | 13 | 7 | -15 | 16 | -12 | -37 | -6 | 63 |
| CFO/OP | 112% | 91% | 94% | 100% | 113% | 66% | 120% | 102% | 100% | 101% | 112% | 99% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 12 | 13 | 12 | 13 | 8 | 8 | 9 | 10 | 10 | 9 | 9 | 9 |
| Inventory Days | 42 | 32 | 28 | 24 | 29 | 59 | 39 | 33 | 36 | 31 | 38 | 31 |
| Days Payable | 169 | 158 | 134 | 143 | 161 | 115 | 117 | 96 | 102 | 113 | 153 | 82 |
| Cash Conversion Cycle | -115 | -112 | -94 | -107 | -125 | -48 | -68 | -53 | -56 | -73 | -105 | -42 |
| Working Capital Days | -70 | -60 | -46 | -37 | -28 | -18 | -15 | -27 | -22 | -73 | -22 | -19 |
| ROCE % | 8% | 24% | 35% | 29% | 29% | 33% | 25% | 32% | 27% | 22% | 17% | 26% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.02% |
| Public | 24.99% | 25.00% | 25.00% | 24.99% | 24.98% | 25.00% | 25.00% | 25.00% | 25.00% | 24.99% | 25.01% | 24.98% |
| No. of Shareholders | 81,967 | 81,439 | 86,328 | 87,801 | 87,612 | 87,875 | 88,009 | 87,252 | 86,958 | 86,344 | 86,318 | 88,487 |
Fundamentals
Market Cap₹ 2,642 Cr.
Current Price₹ 162
Stock P/E47.4
Book Value₹ 12.9
ROCE26.2 %
ROE24.9 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)35%
Compounded Profit Growth (TTM)138%
Standalone figures.
Valuation
Market capRs 2,804 Cr
Enterprise valueRs 2,833 Cr
P/E (TTM)50.28x
Price to book13.33x
Price to sales8.47x
EV / EBITDA26.72x
EV / EBIT33.89x
EV / sales8.56x
Price to cash flow35.45x
Earnings yield1.99%
P/E, 3-year average39.26x
P/B, 3-year average7.14x
P/E, 5-year average38.24x
P/B, 5-year average8.03x
Profitability
Operating margin (excl. other income)28.94%
Operating margin (incl. other income)30.60%
EBITDA margin32.04%
Pre-tax margin22.80%
Net profit margin16.85%
Net margin, latest quarter18.05%
ROE24.94%
ROCE26.25%
ROA15.12%
ROE, 3-year average20.83%
ROCE, 3-year average21.77%
ROA, 3-year average12.19%
ROE, 5-year average24.15%
ROCE, 5-year average24.74%
ROA, 5-year average14.81%
ROIC (approx.)25.89%
Tax rate25.85%
Other income / net worth2.41%
Growth
Sales growth (latest year)32.02%
Profit growth (latest year)118.06%
Sales CAGR, 3 years25.21%
Sales CAGR, 5 years24.40%
Profit CAGR, 3 years20.53%
Profit CAGR, 5 years29.60%
Sales growth QoQ11.59%
Profit growth QoQ13.26%
Sales growth YoY (latest quarter)37.91%
Profit growth YoY (latest quarter)119.76%
Per share
EPS (TTM)Rs 3.42
EPS (latest year)Rs 2.87
EPS (latest quarter)Rs 1.02
EPS, 3-year averageRs 2.01
EPS, 5-year averageRs 1.83
Book value per shareRs 12.90
Sales per shareRs 20.30
Cash flow per shareRs 4.85
Free cash flow per shareRs 3.86
Efficiency
Asset turnover0.92x
Fixed asset turnover1.23x
Inventory turnover34.14x
Inventory days11 days
Debtor days9 days
Debtors turnover41.60x
Creditor days82 days
Cash conversion cycle-42 days
Working capital days-19 days
Leverage
Total debtRs 84 Cr
Cash and bankRs 55 Cr
Net debtRs 29 Cr
Debt to equity0.40x
Net debt / EBITDA0.27x
Interest coverage10.26x
Owners' fund to total sources63.36%
Debt to assets25.20%
Cash flow
Cash from Operating Activity (latest year)Rs 79 Cr
Cash from Investing Activity (latest year)Rs -17 Cr
Cash from Financing Activity (latest year)Rs -21 Cr
Net Cash Flow (latest year)Rs 41 Cr
Free cash flow (latest year)Rs 63 Cr
FCFE (approx.: FCF + change in debt)Rs 57 Cr
Cash from ops / profit, 5 years1.58x
Sales to cash flow3.87x
Statement figures
Net sales (TTM)Rs 331 Cr
Net sales (latest year)Rs 306 Cr
Sales (latest quarter)Rs 92 Cr
Operating profit excl. other income (latest year)Rs 88 Cr
Operating profit (latest quarter)Rs 28 Cr
Other income (TTM)Rs 6 Cr
EBITDA (TTM)Rs 106 Cr
PBDT (TTM)Rs 98 Cr
Profit before tax (TTM)Rs 75 Cr
Tax (latest year)Rs 16 Cr
Net profit (TTM)Rs 56 Cr
Net profit (latest year)Rs 47 Cr
Net profit (latest quarter)Rs 17 Cr
Depreciation (TTM)Rs 22 Cr
Depreciation (latest quarter)Rs 6 Cr
Interest (TTM)Rs 8 Cr
Cost of goods sold (latest year)Rs 132 Cr
Total expenditure (latest year)Rs 217 Cr
Total income (latest year)Rs 311 Cr
Share capitalRs 16 Cr
ReservesRs 194 Cr
Shareholders' fundsRs 210 Cr
Total assetsRs 332 Cr
Net blockRs 248 Cr
InvestmentsRs 0 Cr
ReceivablesRs 7 Cr
InventoryRs 4 Cr
Other liabilitiesRs 38 Cr
Shares outstanding (crore)16.31
Ownership
Promoter holding75.00% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 50.3 is at the 70th percentile of its own 9.4-year range
(median 42.8, low 20.3, high 100.0).
P/B 13.33 is at the 81th percentile (median 9.56).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | KMCSHIL | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +8.9% | -2.8% | +11.7 pts |
| 1 month | +29.0% | -6.8% | +35.8 pts |
| 3 years | +89.3% | +14.2% | +75.1 pts |
| 5 years | +136.0% | +27.9% | +108.1 pts |
1 mutual fund schemes hold about ₹0 Cr.
Over three months 0 bought more and 0 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| Bandhan BSE Healthcare Index Fund | 0.03% | 0 |
Red flags
F-score 8 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹92 Cr +37.3% vs Jun 2025.
Net profit ₹17 Cr +112.5%.
Against our estimate for Jun 2026: sales +2.1%, profit +18.9% beat. Our estimate for Sep 2026: sales Rs 102 Cr, profit Rs 18 Cr (how).
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 124,503 | 59.2 | 17.4 % |
| Manipal Health Enterprises Ltd | 98,357 | 111 | 12.1 % |
| Max Healthcare Institute Ltd | 95,589 | 63.8 | 14.7 % |
| Aster DM Quality Care Ltd | 63,976 | 177 | 11.6 % |
| Fortis Healthcare Ltd | 62,058 | 58.2 | 13.4 % |
| Global Health Ltd | 38,048 | 66.4 | 17.4 % |
| Narayana Hrudayalaya Ltd | 36,579 | 42.4 | 15.5 % |
| Krishna Institute of Medical Sciences Ltd | 32,336 | 155 | 9.50 % |
| Dr Agarwals Health Care Ltd | 15,701 | 106 | 10.9 % |
| Rainbow Childrens Medicare Ltd | 13,892 | 48.5 | 17.4 % |
| Park Medi World Ltd | 11,898 | 42.8 | 19.5 % |
| Yatharth Hospital & Trauma Care Services Ltd | 10,676 | 58.9 | 12.9 % |
| Healthcare Global Enterprises Ltd | 10,505 | 218 | 8.30 % |
| Jupiter Life Line Hospitals Ltd | 8,591 | 44.9 | 14.8 % |
| Kovai Medical Center & Hospital Ltd | 6,579 | 25.7 | 22.6 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Close to Close price movement greater than 25perc in previous 1 month
Quick answers
What is the market cap of KMC Speciality Hospitals (India) Ltd?
KMC Speciality Hospitals (India) Ltd (KMCSHIL) has a market capitalisation of Rs 2,642 Cr. at the 2026-10-01 close.
What is the P/E ratio of KMC Speciality Hospitals (India) Ltd?
KMC Speciality Hospitals (India) Ltd trades at a P/E of 47.4 on trailing twelve-month profit, at the 2026-10-01 close.
What were KMC Speciality Hospitals (India) Ltd's latest quarterly results?
In the Jun 2026 quarter, KMC Speciality Hospitals (India) Ltd sales was Rs 92 Cr (+37.3% vs Jun 2025) and net profit was Rs 17 Cr.
What is the 52-week high and low of KMC Speciality Hospitals (India) Ltd?
The 52-week high is Rs 177.79 and the 52-week low is Rs 128.48.